Trade Report: The Advanced Oncotherapy PLC (AVO) Rating Reiterate by Beaufort Securities

The Advanced Oncotherapy PLC (AVO) Rating Reiterate by Beaufort Securities

Advanced Oncotherapy PLC (LON:AVO)‘s stock had its “speculative buy” rating reissued by analysts at Beaufort Securities in a report issued on Monday.

Advanced Oncotherapy PLC (LON:AVO) opened at 68.01 on Monday. The company’s market capitalization is GBX 38.58 million. Advanced Oncotherapy PLC has a 12-month low of GBX 68.00 and a 12-month high of GBX 217.25. The stock has a 50 day moving average of GBX 100.68 and a 200 day moving average of GBX 127.21.

Related posts

Leave a Comment